A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
Recent Posts
- Join NJACTS on 4/29 for a Multilingual Research Methods Workshop – Register by 4/22!
- NJIT’s Center for Translational Research Quickens Technology’s Pace to Market.
- Join Us for Clinical Trials Day on May 20th!
- Researchers Press for a Rethinking of Childhood Trauma Support in Schools.
- NJACTS Community Engagement Core COVID-19 Resources
Categories
- Community (2,474)
- Covid (999)
- CTO Events (6)
- News (3,137)
- Pilots (21)